Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Increased cerebral blood flow with increased amyloid burden in the preclinical phase of alzheimer's disease.

Fazlollahi A, Calamante F, Liang X, Bourgeat P, Raniga P, Dore V, Fripp J, Ames D, Masters CL, Rowe CC, Connelly A, Villemagne VL, Salvado O; Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group.

J Magn Reson Imaging. 2019 May 30. doi: 10.1002/jmri.26810. [Epub ahead of print]

PMID:
31145515
2.

Comparison of 18F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL® approaches: Validation against histopathology.

Doré V, Bullich S, Rowe CC, Bourgeat P, Konate S, Sabri O, Stephens AW, Barthel H, Fripp J, Masters CL, Dinkelborg L, Salvado O, Villemagne VL, De Santi S.

Alzheimers Dement. 2019 Jun;15(6):807-816. doi: 10.1016/j.jalz.2019.02.005. Epub 2019 May 14.

PMID:
31101517
3.

COMT val158met is not associated with Aβ-amyloid and APOE ε4 related cognitive decline in cognitively normal older adults.

Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Sohrabi HR, Peretti M, Lim YY, Weinborn M, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, Groth D, Verdile G, Villemagne VL, Laws SM.

IBRO Rep. 2019 May 2;6:147-152. doi: 10.1016/j.ibror.2019.05.001. eCollection 2019 Jun.

4.

Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease.

Bransby L, Lim YY, Ames D, Fowler C, Roberston J, Harrington K, Snyder PJ, Villemagne VL, Salvado O, Masters CL, Maruff P for the AIBL Research Group.

J Clin Exp Neuropsychol. 2019 Aug;41(6):591-600. doi: 10.1080/13803395.2019.1593949. Epub 2019 Mar 29.

PMID:
30924399
5.

Klotho allele status is not associated with Aβ and APOE ε4-related cognitive decline in preclinical Alzheimer's disease.

Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Lim YY, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, Groth D, Verdile G, Villemagne VL, Laws SM.

Neurobiol Aging. 2019 Apr;76:162-165. doi: 10.1016/j.neurobiolaging.2018.12.014. Epub 2019 Jan 6.

PMID:
30716541
6.

A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease.

Porter T, Burnham SC, Savage G, Lim YY, Maruff P, Milicic L, Peretti M, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, Taddei K, Groth D, Verdile G, Villemagne VL, Laws SM.

Front Aging Neurosci. 2018 Dec 19;10:423. doi: 10.3389/fnagi.2018.00423. eCollection 2018.

7.

Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.

Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Lim YY, Li QX, Ames D, Masters CL, Rainey-Smith S, Rowe CC, Salvado O, Groth D, Verdile G, Villemagne VL, Laws SM; AIBL Research Group.

J Alzheimers Dis. 2018;66(3):1193-1211. doi: 10.3233/JAD-180713.

PMID:
30412495
8.

Mediterranean diet adherence and rate of cerebral Aβ-amyloid accumulation: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing.

Rainey-Smith SR, Gu Y, Gardener SL, Doecke JD, Villemagne VL, Brown BM, Taddei K, Laws SM, Sohrabi HR, Weinborn M, Ames D, Fowler C, Macaulay SL, Maruff P, Masters CL, Salvado O, Rowe CC, Scarmeas N, Martins RN.

Transl Psychiatry. 2018 Oct 30;8(1):238. doi: 10.1038/s41398-018-0293-5.

9.

Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid β-Associated Cognitive Decline in Older Adults.

Dang C, Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Yassi N, Hickey M, Rainey-Smith SR, Robertson J, Rowe CC, Sohrabi HR, Salvado O, Weinborn M, Villemagne VL, Masters CL, Maruff P; AIBL Research Group.

Arch Clin Neuropsychol. 2018 Oct 1. doi: 10.1093/arclin/acy078. [Epub ahead of print]

PMID:
30272115
10.

Patient with ALS with a novel TBK1 mutation, widespread brain involvement, behaviour changes and metabolic dysfunction.

McCombe PA, Ngo ST, Guo CC, Fazlollahi A, Bollmann S, Wang L, Hu X, Barth M, Salvado O, Davis M, Ceslis A, Robinson G, Henderson RD, Steyn FJ.

J Neurol Neurosurg Psychiatry. 2019 Aug;90(8):952-954. doi: 10.1136/jnnp-2018-318823. Epub 2018 Sep 8. No abstract available.

11.

A lightweight rapid application development framework for biomedical image analysis.

Chandra SS, Dowling JA, Engstrom C, Xia Y, Paproki A, Neubert A, Rivest-Hénault D, Salvado O, Crozier S, Fripp J.

Comput Methods Programs Biomed. 2018 Oct;164:193-205. doi: 10.1016/j.cmpb.2018.07.011. Epub 2018 Jul 26.

PMID:
30195427
12.

MRI white matter lesion segmentation using an ensemble of neural networks and overcomplete patch-based voting.

Manjón JV, Coupé P, Raniga P, Xia Y, Desmond P, Fripp J, Salvado O.

Comput Med Imaging Graph. 2018 Nov;69:43-51. doi: 10.1016/j.compmedimag.2018.05.001. Epub 2018 May 3.

PMID:
30172092
13.

Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults.

Dang C, Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Yassi N, Hickey M, Rainey-Smith S, Robertson J, Sohrabi HR, Salvado O, Weinborn M, Villemagne VL, Rowe CC, Masters CL, Maruff P; AIBL Research Group.

J Alzheimers Dis. 2018;65(4):1313-1325. doi: 10.3233/JAD-180507.

PMID:
30149452
14.

Implementing the centiloid transformation for 11C-PiB and β-amyloid 18F-PET tracers using CapAIBL.

Bourgeat P, Doré V, Fripp J, Ames D, Masters CL, Salvado O, Villemagne VL, Rowe CC; AIBL research group.

Neuroimage. 2018 Dec;183:387-393. doi: 10.1016/j.neuroimage.2018.08.044. Epub 2018 Aug 18.

PMID:
30130643
15.

Estimates of age-related memory decline are inflated by unrecognized Alzheimer's disease.

Harrington KD, Schembri A, Lim YY, Dang C, Ames D, Hassenstab J, Laws SM, Rainey-Smith S, Robertson J, Rowe CC, Sohrabi HR, Salvado O, Weinborn M, Villemagne VL, Masters CL, Maruff P; AIBL Research Group.

Neurobiol Aging. 2018 Oct;70:170-179. doi: 10.1016/j.neurobiolaging.2018.06.005. Epub 2018 Jun 11.

PMID:
30015036
16.

Reply: Cortical tau pathology: a major player in fibre-specific white matter reductions in Alzheimer's disease?

Mito R, Raffelt D, Dhollander T, Vaughan DN, Tournier JD, Salvado O, Brodtmann A, Rowe CC, Villemagne VL, Connelly A.

Brain. 2018 Jun 1;141(6):e45. doi: 10.1093/brain/awy086. No abstract available.

PMID:
29668851
17.

Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.

Martins RN, Villemagne V, Sohrabi HR, Chatterjee P, Shah TM, Verdile G, Fraser P, Taddei K, Gupta VB, Rainey-Smith SR, Hone E, Pedrini S, Lim WL, Martins I, Frost S, Gupta S, O'Bryant S, Rembach A, Ames D, Ellis K, Fuller SJ, Brown B, Gardener SL, Fernando B, Bharadwaj P, Burnham S, Laws SM, Barron AM, Goozee K, Wahjoepramono EJ, Asih PR, Doecke JD, Salvado O, Bush AI, Rowe CC, Gandy SE, Masters CL.

J Alzheimers Dis. 2018;62(3):965-992. doi: 10.3233/JAD-171145. Review.

18.

Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain Aβ-amyloid burden.

Rainey-Smith SR, Mazzucchelli GN, Villemagne VL, Brown BM, Porter T, Weinborn M, Bucks RS, Milicic L, Sohrabi HR, Taddei K, Ames D, Maruff P, Masters CL, Rowe CC, Salvado O, Martins RN, Laws SM; AIBL Research Group.

Transl Psychiatry. 2018 Feb 26;8(1):47. doi: 10.1038/s41398-018-0094-x.

19.

Local contrast-enhanced MR images via high dynamic range processing.

Chandra SS, Engstrom C, Fripp J, Neubert A, Jin J, Walker D, Salvado O, Ho C, Crozier S.

Magn Reson Med. 2018 Sep;80(3):1206-1218. doi: 10.1002/mrm.27109. Epub 2018 Feb 4. No abstract available.

PMID:
29399889
20.

Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β.

Fernando WMADB, Rainey-Smith SR, Gardener SL, Villemagne VL, Burnham SC, Macaulay SL, Brown BM, Gupta VB, Sohrabi HR, Weinborn M, Taddei K, Laws SM, Goozee K, Ames D, Fowler C, Maruff P, Masters CL, Salvado O, Rowe CC, Martins RN; AIBL Research Group.

J Alzheimers Dis. 2018;61(4):1589-1598. doi: 10.3233/JAD-170742.

PMID:
29376865
21.

Amyloid burden and incident depressive symptoms in preclinical Alzheimer's disease.

Perin S, Harrington KD, Lim YY, Ellis K, Ames D, Pietrzak RH, Schembri A, Rainey-Smith S, Salvado O, Laws SM, Martins RN, Villemagne VL, Rowe CC, Masters CL, Maruff P; AIBL research group.

J Affect Disord. 2018 Mar 15;229:269-274. doi: 10.1016/j.jad.2017.12.101. Epub 2018 Jan 3.

PMID:
29329059
22.

Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment.

Mito R, Raffelt D, Dhollander T, Vaughan DN, Tournier JD, Salvado O, Brodtmann A, Rowe CC, Villemagne VL, Connelly A.

Brain. 2018 Mar 1;141(3):888-902. doi: 10.1093/brain/awx355.

PMID:
29309541
23.

A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study.

Villemagne VL, Rowe CC, Barnham KJ, Cherny R, Woodward M, Bozinosvski S, Salvado O, Bourgeat P, Perez K, Fowler C, Rembach A, Maruff P, Ritchie C, Tanzi R, Masters CL.

Alzheimers Dement (N Y). 2017 Nov 9;3(4):622-635. doi: 10.1016/j.trci.2017.10.001. eCollection 2017 Nov.

24.

Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline.

Ayton S, Fazlollahi A, Bourgeat P, Raniga P, Ng A, Lim YY, Diouf I, Farquharson S, Fripp J, Ames D, Doecke J, Desmond P, Ordidge R, Masters CL, Rowe CC, Maruff P, Villemagne VL; Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group, Salvado O, Bush AI.

Brain. 2017 Aug 1;140(8):2112-2119. doi: 10.1093/brain/awx137.

PMID:
28899019
25.

Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults.

Laws SM, Gaskin S, Woodfield A, Srikanth V, Bruce D, Fraser PE, Porter T, Newsholme P, Wijesekara N, Burnham S, Doré V, Li QX, Maruff P, Masters CL, Rainey-Smith S, Rowe CC, Salvado O, Villemagne VL, Martins RN, Verdile G.

Sci Rep. 2017 Aug 29;7(1):9766. doi: 10.1038/s41598-017-09577-4.

26.

Amyloid β-associated cognitive decline in the absence of clinical disease progression and systemic illness.

Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Martins RN, Rainey-Smith S, Robertson J, Rowe CC, Salvado O, Doré V, Villemagne VL, Snyder PJ, Masters CL, Maruff P.

Alzheimers Dement (Amst). 2017 Jun 9;8:156-164. doi: 10.1016/j.dadm.2017.05.006. eCollection 2017.

27.

Trajectories of depressive and anxiety symptoms in older adults: a 6-year prospective cohort study.

Holmes SE, Esterlis I, Mazure CM, Lim YY, Ames D, Rainey-Smith S, Fowler C, Ellis K, Martins RN, Salvado O, Doré V, Villemagne VL, Rowe CC, Laws SM, Masters CL, Pietrzak RH, Maruff P; Australian Imaging, Biomarkers and Lifestyle Research Group.

Int J Geriatr Psychiatry. 2018 Feb;33(2):405-413. doi: 10.1002/gps.4761. Epub 2017 Jul 24.

28.

BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF.

Lim YY, Rainey-Smith S, Lim Y, Laws SM, Gupta V, Porter T, Bourgeat P, Ames D, Fowler C, Salvado O, Villemagne VL, Rowe CC, Masters CL, Zhou XF, Martins RN, Maruff P.

Int Psychogeriatr. 2017 Nov;29(11):1825-1834. doi: 10.1017/S1041610217001284. Epub 2017 Jul 19.

PMID:
28720165
29.

Partial volume model for brain MRI scan using MP2RAGE.

Duché Q, Saint-Jalmes H, Acosta O, Raniga P, Bourgeat P, Doré V, Egan GF, Salvado O.

Hum Brain Mapp. 2017 Oct;38(10):5115-5127. doi: 10.1002/hbm.23719. Epub 2017 Jul 5.

PMID:
28677254
30.

Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals.

Lim YY, Williamson R, Laws SM, Villemagne VL, Bourgeat P, Fowler C, Rainey-Smith S, Salvado O, Martins RN, Rowe CC, Masters CL, Maruff P; AIBL Research Group.

J Alzheimers Dis. 2017;58(4):1293-1302. doi: 10.3233/JAD-170072.

PMID:
28550258
31.

APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults.

Hollands S, Lim YY, Laws SM, Villemagne VL, Pietrzak RH, Harrington K, Porter T, Snyder P, Ames D, Fowler C, Rainey-Smith SR, Martins RN, Salvado O, Robertson J, Rowe CC, Masters CL, Maruff P; AIBL Research Group.

J Alzheimers Dis. 2017;57(2):411-422. doi: 10.3233/JAD-161019.

PMID:
28234254
32.

Aβ-amyloid and Tau Imaging in Dementia.

Villemagne VL, Doré V, Bourgeat P, Burnham SC, Laws S, Salvado O, Masters CL, Rowe CC.

Semin Nucl Med. 2017 Jan;47(1):75-88. doi: 10.1053/j.semnuclmed.2016.09.006. Epub 2016 Oct 13. Review.

PMID:
27987560
33.

Using Robust Normative Data to Investigate the Neuropsychology of Cognitive Aging.

Harrington KD, Lim YY, Ames D, Hassenstab J, Rainey-Smith S, Robertson J, Salvado O, Masters CL, Maruff P; AIBL Research Group.

Arch Clin Neuropsychol. 2017 Mar 1;32(2):142-154. doi: 10.1093/arclin/acw106.

PMID:
27932344
34.

β-Amyloid, APOE and BDNF Genotype, and Depressive and Anxiety Symptoms in Cognitively Normal Older Women and Men.

Holmes SE, Esterlis I, Mazure CM, Lim YY, Ames D, Rainey-Smith S, Martins RN, Salvado O, Dore V, Villemagne VL, Rowe CC, Laws SM, Masters CL, Maruff P, Pietrzak RH; Australian Imaging, Biomarkers, Lifestyle Research Group.

Am J Geriatr Psychiatry. 2016 Dec;24(12):1191-1195. doi: 10.1016/j.jagp.2016.08.007. Epub 2016 Aug 17.

PMID:
27742526
35.

Alterations in dorsal and ventral posterior cingulate connectivity in APOE ε4 carriers at risk of Alzheimer's disease.

Kerestes R, Phal PM, Steward C, Moffat BA, Salinas S, Cox KL, Ellis KA, Cyarto EV, Ames D, Martins RN, Masters CL, Rowe CC, Sharman MJ, Salvado O, Szoeke C, Lai M, Lautenschlager NT, Desmond PM.

BJPsych Open. 2015 Nov 9;1(2):139-148. eCollection 2015 Oct.

36.

Performance on the Cogstate Brief Battery Is Related to Amyloid Levels and Hippocampal Volume in Very Mild Dementia.

Lim YY, Villemagne VL, Laws SM, Pietrzak RH, Ames D, Fowler C, Rainey-Smith S, Snyder PJ, Bourgeat P, Martins RN, Salvado O, Rowe CC, Masters CL, Maruff P; AIBL Research Group.

J Mol Neurosci. 2016 Nov;60(3):362-370. Epub 2016 Sep 1.

PMID:
27586003
37.

Automated visibility map of the internal colon surface from colonoscopy video.

Armin MA, Chetty G, De Visser H, Dumas C, Grimpen F, Salvado O.

Int J Comput Assist Radiol Surg. 2016 Sep;11(9):1599-610. doi: 10.1007/s11548-016-1462-8. Epub 2016 Aug 4.

PMID:
27492067
38.

Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.

Burnham SC, Bourgeat P, Doré V, Savage G, Brown B, Laws S, Maruff P, Salvado O, Ames D, Martins RN, Masters CL, Rowe CC, Villemagne VL; AIBL Research Group.

Lancet Neurol. 2016 Sep;15(10):1044-53. doi: 10.1016/S1474-4422(16)30125-9. Epub 2016 Jul 20.

PMID:
27450471
39.

Federated optimisation of kinetic analysis problems.

Dowson N, Baker C, Thomas P, Smith J, Puttick S, Bell C, Salvado O, Rose S.

Med Image Anal. 2017 Jan;35:116-132. doi: 10.1016/j.media.2016.06.019. Epub 2016 Jun 16.

PMID:
27352142
40.

Alzheimer's Disease and the Early Signs of Age-Related Macular Degeneration.

Frost S, Guymer R, Aung KZ, Macaulay SL, Sohrabi HR, Bourgeat P, Salvado O, Rowe CC, Ames D, Masters CL, Martins RN, Kanagasingam Y; AIBL Research Group.

Curr Alzheimer Res. 2016;13(11):1259-1266.

PMID:
27335042
41.

Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score.

Lim YY, Snyder PJ, Pietrzak RH, Ukiqi A, Villemagne VL, Ames D, Salvado O, Bourgeat P, Martins RN, Masters CL, Rowe CC, Maruff P.

Alzheimers Dement (Amst). 2015 Dec 12;2:19-26. doi: 10.1016/j.dadm.2015.11.003. eCollection 2016.

42.

Amyloid burden and incident depressive symptoms in cognitively normal older adults.

Harrington KD, Gould E, Lim YY, Ames D, Pietrzak RH, Rembach A, Rainey-Smith S, Martins RN, Salvado O, Villemagne VL, Rowe CC, Masters CL, Maruff P; AIBL Research Group.

Int J Geriatr Psychiatry. 2017 Apr;32(4):455-463. doi: 10.1002/gps.4489. Epub 2016 Apr 25.

PMID:
27114112
43.

Cerebral Glucose Metabolism is Associated with Verbal but not Visual Memory Performance in Community-Dwelling Older Adults.

Gardener SL, Sohrabi HR, Shen KK, Rainey-Smith SR, Weinborn M, Bates KA, Shah T, Foster JK, Lenzo N, Salvado O, Laske C, Laws SM, Taddei K, Verdile G, Martins RN.

J Alzheimers Dis. 2016 Mar 31;52(2):661-72. doi: 10.3233/JAD-151084.

PMID:
27031482
44.

Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer disease.

Lim YY, Laws SM, Villemagne VL, Pietrzak RH, Porter T, Ames D, Fowler C, Rainey-Smith S, Snyder PJ, Martins RN, Salvado O, Bourgeat P, Rowe CC, Masters CL, Maruff P.

Neurology. 2016 Apr 26;86(17):1635-42. doi: 10.1212/WNL.0000000000002604. Epub 2016 Mar 30.

PMID:
27029632
45.

Heritability and genetic correlation between the cerebral cortex and associated white matter connections.

Shen KK, Doré V, Rose S, Fripp J, McMahon KL, de Zubicaray GI, Martin NG, Thompson PM, Wright MJ, Salvado O.

Hum Brain Mapp. 2016 Jun;37(6):2331-47. doi: 10.1002/hbm.23177. Epub 2016 Mar 23.

46.

Statistical machine learning to identify traumatic brain injury (TBI) from structural disconnections of white matter networks.

Mitra J, Shen KK, Ghose S, Bourgeat P, Fripp J, Salvado O, Pannek K, Taylor DJ, Mathias JL, Rose S.

Neuroimage. 2016 Apr 1;129:247-259. doi: 10.1016/j.neuroimage.2016.01.056. Epub 2016 Jan 28.

PMID:
26827816
47.

Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.

Zwan MD, Villemagne VL, Doré V, Buckley R, Bourgeat P, Veljanoski R, Salvado O, Williams R, Margison L, Rembach A, Macaulay SL, Martins R, Ames D, van der Flier WM, Ellis KA, Scheltens P, Masters CL, Rowe CC.

J Alzheimers Dis. 2016;49(4):1115-22. doi: 10.3233/JAD-150446.

PMID:
26639956
48.

Computer-aided detection of cerebral microbleeds in susceptibility-weighted imaging.

Fazlollahi A, Meriaudeau F, Giancardo L, Villemagne VL, Rowe CC, Yates P, Salvado O, Bourgeat P; AIBL Research Group.

Comput Med Imaging Graph. 2015 Dec;46 Pt 3:269-76. doi: 10.1016/j.compmedimag.2015.10.001. Epub 2015 Oct 24.

PMID:
26560677
49.

Assessing atrophy measurement techniques in dementia: Results from the MIRIAD atrophy challenge.

Cash DM, Frost C, Iheme LO, Ünay D, Kandemir M, Fripp J, Salvado O, Bourgeat P, Reuter M, Fischl B, Lorenzi M, Frisoni GB, Pennec X, Pierson RK, Gunter JL, Senjem ML, Jack CR Jr, Guizard N, Fonov VS, Collins DL, Modat M, Cardoso MJ, Leung KK, Wang H, Das SR, Yushkevich PA, Malone IB, Fox NC, Schott JM, Ourselin S.

Neuroimage. 2015 Dec;123:149-64. doi: 10.1016/j.neuroimage.2015.07.087. Epub 2015 Aug 11.

50.

Using the apparent diffusion coefficient to identifying MGMT promoter methylation status early in glioblastoma: importance of analytical method.

Rundle-Thiele D, Day B, Stringer B, Fay M, Martin J, Jeffree RL, Thomas P, Bell C, Salvado O, Gal Y, Coulthard A, Crozier S, Rose S.

J Med Radiat Sci. 2015 Jun;62(2):92-8. doi: 10.1002/jmrs.103. Epub 2015 Apr 16.

Supplemental Content

Loading ...
Support Center